Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Global Comprehensive Outlook of Hantavirus Contagion on Humans: A Review

Author(s): Sumel Ashique, Navjot K Sandhu*, Supratim Das, Sk. Niyamul Haque and Kartick Koley

Volume 22, Issue 3, 2022

Published on: 18 February, 2022

Article ID: e050122199975 Pages: 10

DOI: 10.2174/1871526522666220105110819

Price: $65

Abstract

Hantaviruses are rodent viruses that have been identified as etiologic agents of 2 diseases in humans: Hemorrhagic Fever with Renal Syndrome (HFRS) and Nephropathiaepidemica (NE) in the Old World and Hantavirus Pulmonary Syndrome (HPS) in the New World. Orthohantavirus is a genus of single-stranded, enveloped, negative-sense RNA viruses in the family Hantaviridae of the order Bunyavirales. The important reservoir of Hantaviruses is rodents. Each virus serotype has its unique rodent host species and is transmitted to human beings with the aid of aerosolized virus, which is shed in urine, faeces and saliva and hardly by a bite of the contaminated host. Andes virus is the only Hantavirus identified to be transmitted from human-to-human and its major signs and symptoms include fever, headache, muscle aches, lungs filled with fluid, etc. In early 1993, this viral syndrome appeared in the Four Corner location in the southwestern United States. The only accepted therapeutics for this virus is Ribavirin. Recently, serological examinations to identify Hantavirus antibodies have become most popular for investigation among humans and rodent reservoirs.

Keywords: Hantavirus, history, pathogenesis, outbreak, sign-symptoms, transmission, treatment.

Graphical Abstract

[1]
New York Post. Available from: https://nypost.com/2020/03/24/ man-who-
[2]
Chandy S, Mathai D. Globally emerging hantaviruses: An overview. Indian J Med Microbiol 2017; 35(2): 165-75.
[http://dx.doi.org/10.4103/ijmm.IJMM_16_429] [PMID: 28681802]
[3]
Kaukinen P, Vaheri A, Plyusnin A. Hantavirus nucleocapsid protein: a multifunctional molecule with both housekeeping and ambassadorial duties. Arch Virol 2005; 150(9): 1693-713.
[http://dx.doi.org/10.1007/s00705-005-0555-4] [PMID: 15931462]
[4]
Johnson KM. Hantaviruses: history and overview. In: Schmaljohn CS, Nichol ST, Eds. Hantaviruses Current Topics in Microbiology and Immunology. Springer: New York 2012.
[5]
Lee HW, Johnson KM. Laboratory-acquired infections with Hantaan virus, the etiologic agent of Korean hemorrhagic fever. J Infect Dis 1982; 146(5): 645-51.
[http://dx.doi.org/10.1093/infdis/146.5.645] [PMID: 6127367]
[6]
Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262(5135): 914-7.
[http://dx.doi.org/10.1126/science.8235615] [PMID: 8235615]
[7]
Avšič-Županc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect 2019; 21S: e6-e16.
[http://dx.doi.org/10.1111/1469-0691.12291] [PMID: 24750436]
[8]
Schudel M. biologist found source of hantavirus Washington Post. Boston Globe 2007; 12-24.
[9]
Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001; 289(1): 6-14.
[http://dx.doi.org/10.1006/viro.2001.1133] [PMID: 11601912]
[10]
Mackow ER, Gavrilovskaya IN. Hantavirus regulation of endothelial cell functions. Thromb Haemost 2009; 102(6): 1030-41.
[PMID: 19967132]
[11]
Vapalahti O, Lundkvist Å, Vaheri A. Human immune response, host genetics, and severity of disease. In: Hanta viruses. Berlin, Heidelberg: Springer 2001; pp. 153-69.
[http://dx.doi.org/10.1007/978-3-642-56753-7_9]
[12]
Kim S, Kang ET, Kim YG, et al. Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever H. Am J Clin Pathol 1993; 100(4): 398-403.
[http://dx.doi.org/10.1093/ajcp/100.4.398] [PMID: 7692720]
[13]
Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146(3): 552-79.
[PMID: 7887439]
[14]
Terajima M, Hayasaka D, Maeda K, Ennis FA. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Lett 2007; 113(2): 117-20.
[http://dx.doi.org/10.1016/j.imlet.2007.08.003] [PMID: 17897725]
[15]
Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins. J Virol 1999; 73(5): 3951-9.
[http://dx.doi.org/10.1128/JVI.73.5.3951-3959.1999] [PMID: 10196290]
[16]
Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. Pathogenic hantaviruses selectively inhibit β3 integrin directed endothelial cell migration. Arch Virol 2002; 147(10): 1913-31.
[http://dx.doi.org/10.1007/s00705-002-0852-0] [PMID: 12376753]
[17]
Schönrich G, Rang A, Lütteke N, Raftery MJ, Charbonnel N, Ulrich RG. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev 2008; 225(1): 163-89.
[http://dx.doi.org/10.1111/j.1600-065X.2008.00694.x] [PMID: 18837782]
[18]
Hermann D, Selic C, Siccoli M, Werth E, Pollmächer T, Bassetti C. Plasma levels of Tumor Necrosis Factor (TNF) alpha, soluble TNF receptor-1 and-2 are elevated in acute ischemic stroke patients with sleep apnea. Akt Neurol 2004; 31(S1): 612.
[http://dx.doi.org/10.1055/s-2004-833510]
[19]
Hayasaka D, Maeda K, Ennis FA, Terajima M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 2007; 123(2): 120-7.
[http://dx.doi.org/10.1016/j.virusres.2006.08.006] [PMID: 16979772]
[20]
Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 2008; 82(12): 5797-806.
[http://dx.doi.org/10.1128/JVI.02397-07] [PMID: 18367532]
[21]
Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J. Hantaan virus infection of human endothelial cells. J Virol 1992; 66(10): 5929-36.
[http://dx.doi.org/10.1128/jvi.66.10.5929-5936.1992] [PMID: 1356160]
[22]
Bi Z, Formenty PB, Roth CE. Hantavirus infection: a review and global update. J Infect Develop Count 2008; 2(01): 003-23.
[23]
Hart CA, Bennett M. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect 1999; 1(14): 1229-37.
[http://dx.doi.org/10.1016/S1286-4579(99)00238-5] [PMID: 10580279]
[24]
Dournon E, Moriniere B, Matheron S, et al. Hers after a wild rodent bite in the haute-savoie-and risk of exposure to hantaan-uke virus in a paris laboratory. Lancet 1984; 323(8378): 676-7.
[http://dx.doi.org/10.1016/S0140-6736(84)92187-1]
[25]
Enría D, Padula P, Segura EL, et al. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina 1996; 56(6): 709-11.
[PMID: 9284576]
[26]
Wells RM, Sosa Estani S, Yadon ZE, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis 1997; 3(2): 171-4.
[http://dx.doi.org/10.3201/eid0302.970210] [PMID: 9204298]
[27]
Clement J, Underwood P, Ward D, Pilaski J, LeDuc J. Hantavirus outbreak during military manoeuvres in Germany. Lancet 1996; 347(8997): 336.
[http://dx.doi.org/10.1016/S0140-6736(96)90519-X] [PMID: 8569401]
[28]
Deutz A, Fuchs K, Nowotny N, et al. Sero-epidemiological studies of zoonotic infections in hunters--comparative analysis with veterinarians, farmers, and abattoir workers. Wien Klin Wochenschr 2003; 115(Suppl. 3): 61-7.
[PMID: 15508783]
[29]
Heyman P, Vaheri A, Lundkvist A, Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther 2009; 7(2): 205-17.
[http://dx.doi.org/10.1586/14787210.7.2.205] [PMID: 19254169]
[30]
Bi Z, Formenty PB, Roth CE. Hantavirus infection: a review and global update. J Infect DevCtries 2008; 8(01): 003-23.
[31]
Hemorrhagic Fever with Renal Syndrome (HFRS). Available from: https://www.cdc.gov/hantavirus/hfrs/index.html
[32]
Yi J, Xu Z, Zhuang R, et al. Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis 2013; 207(9): 1457-61.
[http://dx.doi.org/10.1093/infdis/jis475] [PMID: 22869912]
[33]
Center for Diseases Control and Prevention. Available from: https://www.cdc.gov/hantavirus/technical/hps/diagnostics
[34]
Brummer-Korvenkontio M, Vaheri A, Hovi T, et al. Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 1980; 141(2): 131-4.
[http://dx.doi.org/10.1093/infdis/141.2.131] [PMID: 6102587]
[35]
Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: Hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 1999; 50(1): 531-45.
[http://dx.doi.org/10.1146/annurev.med.50.1.531] [PMID: 10073292]
[36]
Saksida A, Duh D, Korva M, Avsic-Zupanc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 2008; 197(5): 681-5.
[http://dx.doi.org/10.1086/527485] [PMID: 18269319]
[37]
Krüger DH, Schönrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin 2011; 7(6): 685-93.
[http://dx.doi.org/10.4161/hv.7.6.15197] [PMID: 21508676]
[38]
Kramski M, Meisel H, Klempa B, Krüger DH, Pauli G, Nitsche A. Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing. Clin Chem 2007; 53(11): 1899-905.
[http://dx.doi.org/10.1373/clinchem.2007.093245] [PMID: 17717126]
[39]
U.S National Library of Medicine. Available from: https://clinicaltrials.gov/ct2/results
[40]
Klempa B, Witkowski PT, Popugaeva E, et al. Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses. J Virol 2012; 86(7): 3819-27.
[http://dx.doi.org/10.1128/JVI.05879-11] [PMID: 22278233]
[41]
Witkowski PT, Klempa B, Ithete NL, et al. Hantaviruses in Africa. Virus Res 2014; 187: 34-42.
[http://dx.doi.org/10.1016/j.virusres.2013.12.039] [PMID: 24406800]
[42]
Lee HW. Korean hemorrhagic fever. Korea Univ Seoul DeptOf Microbiology 1974. Available from: https://apps.dtit.mil/citations/ ADO779432.
[43]
Heyman P, Vaheri A. ENIVD Members. Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill 2008; 13(28): 18925-32.
[http://dx.doi.org/10.2807/ese.13.28.18925-en] [PMID: 18761927]
[44]
Avsic-Zupanc T, Nemirov K, Petrovec M, et al. Genetic analysis of wild-type Dobrava hantavirus in Slovenia: co-existence of two distinct genetic lineages within the same natural focus. J Gen Virol 2000; 81(Pt 7): 1747-55.
[http://dx.doi.org/10.1099/0022-1317-81-7-1747] [PMID: 10859380]
[45]
Jakab F, Horváth G, Ferenczi E, Sebők J, Varecza Z, Szűcs G. Detection of Dobrava hantaviruses in Apodemus agrarius mice in the Transdanubian region of Hungary. Virus Res 2007; 128(1-2): 149-52.
[http://dx.doi.org/10.1016/j.virusres.2007.04.015] [PMID: 17524512]
[46]
Klein SL, Calisher CH. Emergence and persistence of hantavirusesInWildlife and emerging zoonotic diseases: the biology, circumstances and consequences of cross-species transmission. Berlin, Heidelberg: Springer 2007; pp. 217-52.
[47]
Garanina SB, Platonov AE, Zhuravlev VI, et al. Genetic diversity and geographic distribution of hantaviruses in Russia. Zoonoses Public Health 2009; 56(6-7): 297-309.
[http://dx.doi.org/10.1111/j.1863-2378.2008.01210.x] [PMID: 19486318]
[48]
Klempa B, Tkachenko EA, Dzagurova TK, et al. Hemorrhagic fever with renal syndrome caused by 2 lineages of Dobrava hantavirus, Russia. Emerg Infect Dis 2008; 14(4): 617-25.
[http://dx.doi.org/10.3201/eid1404.071310] [PMID: 18394280]
[49]
Plyusnin A, Nemirov K, Apekina N, Plyusnina A, Lundkvist A, Vaheri A. Dobrava hantavirus in Russia. Lancet 1999; 353(9148): 207.
[http://dx.doi.org/10.1016/S0140-6736(05)77216-0] [PMID: 9923881]
[50]
Klempa B, Meisel H, Räth S, Bartel J, Ulrich R, Krüger DH. Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol 2003; 41(10): 4894-7.
[http://dx.doi.org/10.1128/JCM.41.10.4894-4897.2003] [PMID: 14532254]
[51]
Sibold C, Meisel H, Lundkvist A, et al. Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am J Trop Med Hyg 1999; 61(3): 409-11.
[http://dx.doi.org/10.4269/ajtmh.1999.61.409] [PMID: 10497981]
[52]
Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A. Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis 1999; 31(5): 427-35.
[http://dx.doi.org/10.1080/00365549950163941] [PMID: 10576121]
[53]
Lee HW. Epidemiology and pathogenesis of hemorrhagic fever with renal syndrome. In: Thebunyaviridae. Boston: Springer 1996; pp. 253-67.
[54]
Yan L, Fang LQ, Huang HG, et al. Landscape elements and Hantaan virus-related hemorrhagic fever with renal syndrome, People’s Republic of China. Emerg Infect Dis 2007; 13(9): 1301-6.
[http://dx.doi.org/10.3201/eid1309.061481] [PMID: 18252099]
[55]
Song KJ, Baek LJ, Moon S, et al. Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. J Gen Virol 2007; 88(Pt 11): 3121-9.
[http://dx.doi.org/10.1099/vir.0.83139-0] [PMID: 17947538]
[56]
Tappero JW, Khan AS, Pinner RW, et al. Utility of emergency, telephone-based national surveillance for Hantavirus pulmonary syndrome. Hantavirus Task Force. JAMA 1996; 275(5): 398-400.
[http://dx.doi.org/10.1001/jama.1996.03530290068039] [PMID: 8569020]
[57]
Williams RJ, Bryan RT, Mills JN, et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg 1997; 57(3): 274-82.
[http://dx.doi.org/10.4269/ajtmh.1997.57.274] [PMID: 9311636]
[58]
Toro J, Vega JD, Khan AS, et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 1998; 4(4): 687-94.
[http://dx.doi.org/10.3201/eid0404.980425] [PMID: 9866751]
[59]
Baró M, Vergara J, Navarrete M. Hantavirus in Chile: review and cases analysis since 1975. Rev Med Chil 1999; 127(12): 1513-23.
[http://dx.doi.org/10.4067/S0034-98871999001200015] [PMID: 10835761]
[60]
Vincent MJ, Quiroz E, Gracia F, et al. Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology 2000; 277(1): 14-9.
[http://dx.doi.org/10.1006/viro.2000.0563] [PMID: 11062031]
[61]
Figueiredo LT, Moreli ML, Campos GM, Sousa RL. Hantaviruses in São Paulo State, Brazil. Emerg Infect Dis 2003; 9(7): 891-2.
[http://dx.doi.org/10.3201/eid0907.030087] [PMID: 12899143]
[62]
Figueiredo LT, Moreli ML, de-Sousa RL, et al. Viral Diversity Genetic Network Consortium. Hantavirus pulmonary syndrome, central plateau, southeastern, and southern Brazil. Emerg Infect Dis 2009; 15(4): 561-7.
[http://dx.doi.org/10.3201/eid1504.080289] [PMID: 19331732]
[63]
Mackow ER, Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. In: Hantaviruses. Heidelberg: Springer 2001; pp. 91-115.
[64]
Markotić A, Hensley L, Daddario K, Spik K, Anderson K, Schmaljohn C. Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Coll Antropol 2007; 31(4): 1159-67.
[PMID: 18217475]
[65]
Chizhikov VE, Spiropoulou CF, Morzunov SP, Monroe MC, Peters CJ, Nichol ST. Complete genetic characterization and analysis of isolation of Sin Nombre virus. J Virol 1995; 69(12): 8132-6.
[http://dx.doi.org/10.1128/jvi.69.12.8132-8136.1995] [PMID: 7494336]
[66]
Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER. β3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 1998; 95(12): 7074-9.
[http://dx.doi.org/10.1073/pnas.95.12.7074] [PMID: 9618541]
[67]
Ravkov EV, Nichol ST, Compans RW. Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus. J Virol 1997; 71(2): 1147-54.
[http://dx.doi.org/10.1128/jvi.71.2.1147-1154.1997] [PMID: 8995636]
[68]
Rowe RK, Pekosz A. Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J Virol 2006; 80(3): 1087-97.
[http://dx.doi.org/10.1128/JVI.80.3.1087-1097.2006] [PMID: 16414986]
[69]
Jin M, Park J, Lee S, et al. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 2002; 294(1): 60-9.
[http://dx.doi.org/10.1006/viro.2001.1303] [PMID: 11886265]
[70]
Betenbaugh M, Yu M, Kuehl K, et al. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. Virus Res 1995; 38(2-3): 111-24.
[http://dx.doi.org/10.1016/0168-1702(95)00053-S] [PMID: 8578853]
[71]
Schmaljohn CS, Jonsson CB. Replication of hantaviruses Hantaviruses. Berlin: Springer-Verlag 2001; pp. 15-32.
[http://dx.doi.org/10.1007/978-3-642-56753-7]
[72]
Ramanathan HN, Chung DH, Plane SJ, et al. Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment. J Virol 2007; 81(16): 8634-47.
[http://dx.doi.org/10.1128/JVI.00418-07] [PMID: 17537852]
[73]
Ramanathan HN, Jonsson CB. New and Old World hantaviruses differentially utilize host cytoskeletal components during their life cycles. Virology 2008; 374(1): 138-50.
[http://dx.doi.org/10.1016/j.virol.2007.12.030] [PMID: 18234268]
[74]
Löber C, Anheier B, Lindow S, Klenk HD, Feldmann H. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 2001; 289(2): 224-9.
[http://dx.doi.org/10.1006/viro.2001.1171] [PMID: 11689045]
[75]
Haque A, Mir MA. Interaction of hantavirus nucleocapsid protein with ribosomal protein S19. J Virol 2010; 84(23): 12450-3.
[http://dx.doi.org/10.1128/JVI.01388-10] [PMID: 20844026]
[76]
Armstrong LR, Zaki SR, Goldoft MJ, et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis 1995; 172(4): 1166.
[http://dx.doi.org/10.1093/infdis/172.4.1166] [PMID: 7561206]
[77]
Pugliese G. Hantavirus-associated illness identified in North Dakota. Infect Control Hosp Epidemiol 1993; 14(11): 673.
[PMID: 7907617]
[78]
Centers for Disease Control. Hantavirus infection--southwestern United States: interim recommendations for risk reduction. US Department of Health and Human Services, Public Health Service. Centers Dis Control Prevention 1993; 42: 1-13.
[79]
Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus infections in humans and animals, China. Emerg Infect Dis 2010; 16(8): 1195-203.
[http://dx.doi.org/10.3201/eid1608.090470] [PMID: 20678311]
[80]
Huggins JW, Kim GR, Brand OM, McKee KT Jr. Ribavirin therapy for Hantaan virus infection in suckling mice. J Infect Dis 1986; 153(3): 489-97.
[http://dx.doi.org/10.1093/infdis/153.3.489] [PMID: 2869089]
[81]
Huggins JW. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 1989; 11(Suppl. 4): S750-61.
[http://dx.doi.org/10.1093/clinids/11.Supplement_4.S750] [PMID: 2546248]
[82]
Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164(6): 1119-27.
[http://dx.doi.org/10.1093/infdis/164.6.1119] [PMID: 1683355]
[83]
Chapman LE, Mertz GJ, Peters CJ, et al. Ribavirin Study Group. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antivir Ther 1999; 4(4): 211-9.
[PMID: 10723500]
[84]
Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA. Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis 2006; 19(5): 437-42.
[http://dx.doi.org/10.1097/01.qco.0000244048.38758.1f] [PMID: 16940866]
[85]
Rusnak JM, Byrne WR, Chung KN, et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res 2009; 81(1): 68-76.
[http://dx.doi.org/10.1016/j.antiviral.2008.09.007] [PMID: 18977392]
[86]
Antoniades A, Grekas D, Rossi CA, LeDuc JW. Isolation of a hantavirus from a severely ill patient with hemorrhagic fever with renal syndrome in Greece. J Infect Dis 1987; 156(6): 1010-3.
[http://dx.doi.org/10.1093/infdis/156.6.1010] [PMID: 2890690]
[87]
Kariwa H, Arikawa J, Takashima I, Hashimoto N. Development and application of protein G antibody assay for the detection of antibody to hantavirus. J Virol Methods 1992; 37(3): 345-54.
[http://dx.doi.org/10.1016/0166-0934(92)90034-B] [PMID: 1634601]
[88]
Manigold T, Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med Wkly 2014; 144: w13937-47.
[http://dx.doi.org/10.4414/smw.2014.13937] [PMID: 24652684]
[89]
Schmaljohn CS, Hasty SE, Dalrymple JM. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 1992; 10(1): 10-3.
[http://dx.doi.org/10.1016/0264-410X(92)90412-D] [PMID: 1347189]
[90]
Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. Vaccine 2008; 26(40): 5177-81.
[http://dx.doi.org/10.1016/j.vaccine.2008.03.097] [PMID: 18482782]
[91]
Maes P, Clement J, Van Ranst M. Recent approaches in hantavirus vaccine development. Expert Rev Vaccines 2009; 8(1): 67-76.
[http://dx.doi.org/10.1586/14760584.8.1.67] [PMID: 19093774]
[92]
Tian H, Stenseth NC. The ecological dynamics of hantavirus diseases: From environmental variability to disease prevention largely based on data from China. PLoS Negl Trop Dis 2019; 13(2): e0006901.
[http://dx.doi.org/10.1371/journal.pntd.0006901] [PMID: 30789905]
[93]
Cho HW, Howard CR, Lee HW. Review of an inactivated vaccine against hantaviruses. Intervirology 2002; 45(4-6): 328-33.
[http://dx.doi.org/10.1159/000067925] [PMID: 12602351]
[94]
Jung J, Ko SJ, Oh HS, Moon SM, Song JW, Huh K. Protective effectiveness of inactivated Hantavirus vaccine against hemorrhagic fever with renal syndrome. J Infect Dis 2018; 217(9): 1417-20.
[http://dx.doi.org/10.1093/infdis/jiy037] [PMID: 29373686]
[95]
Li Z, Zeng H, Wang Y, et al. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China. Hum Vaccin Immunother 2017; 13(4): 802-7.
[http://dx.doi.org/10.1080/21645515.2016.1253645] [PMID: 27824286]
[96]
Yong CY, Ong HK, Yeap SK, Ho KL, Tan WS. Recent advances in the vaccine development against middle east respiratory syndrome-coronavirus. Front Microbiol 2019; 10: 1781-99.
[http://dx.doi.org/10.3389/fmicb.2019.01781] [PMID: 31428074]
[97]
Cheng LF, Wang F, Zhang L, et al. Incorporation of GM-CSF or CD40L enhances the immunogenicity of hantaan virus-like particles. Front Cell Infect Microbiol 2016; 6: 185-203.
[http://dx.doi.org/10.3389/fcimb.2016.00185] [PMID: 28066721]
[98]
Ying Q, Ma T, Cheng L, et al. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle. Oncotarget 2016; 7(39): 63488-503.
[http://dx.doi.org/10.18632/oncotarget.11329] [PMID: 27542281]
[99]
Dong Y, Ma T, Zhang X, et al. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection. J Med Microbiol 2019; 68(3): 480-92.
[http://dx.doi.org/10.1099/jmm.0.000897] [PMID: 30657443]
[100]
Sayer WJ, Entwhisle G, Uyeno B, Bignall RC. Cortisone therapy of early epidemic hemorrhagic fever: a preliminary report. Ann Intern Med 1955; 42(4): 839-51.
[http://dx.doi.org/10.7326/0003-4819-42-4-839] [PMID: 14362256]
[101]
Brocato RL, Hooper JW. Progress on the prevention and treatment of hantavirus disease. Viruses 2019; 11(7): 610-24.
[http://dx.doi.org/10.3390/v11070610] [PMID: 31277410]
[102]
Hanta Virus. Available from: https://clinicaltrials.gov/ct2/resultscond=HANTAVIRUS

Rights & Permissions Print Cite
Article Metrics
16
1
© 2024 Bentham Science Publishers | Privacy Policy